Clin2
NCT07156500Likely a fitNot yet recruiting

Study of a new drug for type 2 diabetes not controlled by diet and exercise

Type 2 Diabetes

Part of Hormones & metabolism clinical trials.

This trial tests a new medicine, HS-20094, for people with type 2 diabetes whose blood sugar is not well controlled by diet and exercise alone. It aims to see if the drug can help lower blood sugar levels.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 3
Enrollment
204 people
Ages
18 years and older
Study type
Interventional

Who can take part

  • You are 18 years or older
  • You have been diagnosed with type 2 diabetes for at least 3 months
  • You have been managing your diabetes with only diet and exercise for at least 3 months
  • Your HbA1c (average blood sugar over 3 months) is between 7.5% and 10.5%

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07394114Recruiting· Phase 3
Study of a new medicine for type 2 diabetes not controlled by diet and exercise

This trial tests a new medicine called HDM1005 for people with type 2 diabetes who haven't been helped enough by diet and exercise alone, and who haven't taken any diabetes medication in the last 12 weeks. It aims to see if the medicine can help lower blood sugar levels safely.

Beijing
NCT07109700Recruiting· Phase 2
New injectable study for type 2 diabetes

This study tests a new once-weekly injectable medication (HDM1005) for people with type 2 diabetes whose blood sugar is not well controlled by diet and exercise or metformin alone. It aims to help lower blood sugar and may also support weight loss.

Beijing, Beijing Municipality
NCT07060456Recruiting· Phase 3
New drug for type 2 diabetes with insulin

This trial tests a new medicine called HRS9531 for people with type 2 diabetes who already use basal insulin. It aims to see if adding this drug helps control blood sugar better.

Beijing, Beijing Municipality
NCT07417306Not yet recruiting· Phase 3
New drug for type 2 diabetes not well controlled on metformin

This trial tests an investigational drug called HDM1005 for people with type 2 diabetes whose blood sugar is still high despite taking metformin (with or without another diabetes pill called an SGLT2 inhibitor). The goal is to see if the new drug can better lower blood sugar levels.

Beijing
NCT07193459Recruiting· Phase 3
Study of an oral tablet for type 2 diabetes

This trial tests an experimental daily tablet for adults with type 2 diabetes who are not currently on any diabetes medication. It aims to see if the tablet can safely lower blood sugar levels over time.

Beijing, Beijing Municipality
NCT07156539Not yet recruiting· Phase 3
Study of an investigational diabetes drug

This trial tests an investigational medication (HS-20094) for people with type 2 diabetes. It aims to see if it can help control blood sugar and possibly support weight loss.

Jinan, Shandong

Hear when a new Type 2 diabetes trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.